Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

SGX:T14 Statistics

Total Valuation

SGX:T14 has a market cap or net worth of SGD 5.30 billion. The enterprise value is 4.40 billion.

Market Cap	5.30B
Enterprise Value	4.40B

Important Dates

The next estimated earnings date is Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	Jun 25, 2025

Share Statistics

Current Share Class	200.00M
Shares Outstanding	n/a
Shares Change (YoY)	-0.44%
Shares Change (QoQ)	+1.91%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	421.34M

Valuation Ratios

The trailing PE ratio is 8.52.

PE Ratio	8.52
Forward PE	n/a
PS Ratio	4.98
PB Ratio	3.39
P/TBV Ratio	3.51
P/FCF Ratio	40.57
P/OCF Ratio	34.78
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.16, with an EV/FCF ratio of 33.66.

EV / Earnings	7.07
EV / Sales	4.09
EV / EBITDA	26.16
EV / EBIT	29.87
EV / FCF	33.66

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.00.

Current Ratio	2.06
Quick Ratio	1.74
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.03
Interest Coverage	30.20

Financial Efficiency

Return on equity (ROE) is 46.15% and return on invested capital (ROIC) is 6.32%.

Return on Equity (ROE)	46.15%
Return on Assets (ROA)	4.14%
Return on Invested Capital (ROIC)	6.32%
Return on Capital Employed (ROCE)	9.21%
Revenue Per Employee	230,603
Profits Per Employee	134,657
Employee Count	4,619
Asset Turnover	0.48
Inventory Turnover	1.79

Taxes

In the past 12 months, SGX:T14 has paid 108.61 million in taxes.

Income Tax	108.61M
Effective Tax Rate	14.91%

Stock Price Statistics

The stock price has increased by +37.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+37.38%
50-Day Moving Average	2.77
200-Day Moving Average	2.36
Relative Strength Index (RSI)	54.53
Average Volume (20 Days)	205,105

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGX:T14 had revenue of SGD 1.07 billion and earned 621.98 million in profits. Earnings per share was 0.81.

Revenue	1.07B
Gross Profit	623.90M
Operating Income	145.66M
Pretax Income	728.44M
Net Income	621.98M
EBITDA	165.65M
EBIT	145.66M
Earnings Per Share (EPS)	0.81

Balance Sheet

The company has 901.34 million in cash and 4.04 million in debt, giving a net cash position of 897.30 million.

Cash & Cash Equivalents	901.34M
Total Debt	4.04M
Net Cash	897.30M
Net Cash Per Share	n/a
Equity (Book Value)	1.56B
Book Value Per Share	2.03
Working Capital	745.83M

Cash Flow

In the last 12 months, operating cash flow was 152.37 million and capital expenditures -21.74 million, giving a free cash flow of 130.62 million.

Operating Cash Flow	152.37M
Capital Expenditures	-21.74M
Free Cash Flow	130.62M
FCF Per Share	n/a

Margins

Gross margin is 58.57%, with operating and profit margins of 13.67% and 58.39%.

Gross Margin	58.57%
Operating Margin	13.67%
Pretax Margin	68.39%
Profit Margin	58.39%
EBITDA Margin	15.55%
EBIT Margin	13.67%
FCF Margin	12.26%

Dividends & Yields

This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 7.66%.

Dividend Per Share	0.23
Dividend Yield	7.66%
Dividend Growth (YoY)	5.95%
Years of Dividend Growth	7
Payout Ratio	28.56%
Buyback Yield	0.44%
Shareholder Yield	8.10%
Earnings Yield	11.74%
FCF Yield	2.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 30, 2010. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2010
Split Type	Forward
Split Ratio	2

Scores

SGX:T14 has an Altman Z-Score of 4.98 and a Piotroski F-Score of 6.

Altman Z-Score	4.98
Piotroski F-Score	6